|
⚲
|
| Goldman Sachs Hedge Fund Portfolio III PLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001291562 |
| Sale | 2004-05-01 ($92.9 M Sold) |
| Fund | |
| Phone | 2129021000 |
| Address | One New York Plaza New York, 10004 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Frank Ennis | |
| Kent Clark | |
| Jennifer Barbetta | |
| Alan Shuch | |
| David Shubotham | |
| Theodore Sotir | |
| Eugene Regan |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
CRIA Inc
✚
|
0.0 | |
|
Crisp Charles R
✚
|
0.0 | |
|
CRISPR Therapeutics AG
✚
|
0.0 | |
|
Crist Peter D
✚
|
0.0 | |
|
6710 Equity LLC
✚
|
0.0 | |
|
Arborlight Inc.
✚
|
0.0 | |
|
Arbor Venture Emerging Markets Fund II, L.P.
✚
|
0.0 | |
|
Arbor Weymouth Investor LLC
✚
|
0.0 | |
|
ARCA biopharma, Inc.
✚
|
0.0 | |
|
Antares Venture Group LLC
✚
|
0.0 |